Results 131 to 140 of about 2,572,587 (193)

Does the Type of Cannula Matter? A Case Report and Review of the Evidence Regarding Steel and Plastic Cannulae With Respect to a Continuous Subcutaneous Insulin Infusion. [PDF]

Cureus
Barnett MJ, Prater J, Green L, Mayrin J.
europepmc   +1 more source

One-Year Real-World Study on Comparison among Different Continuous Subcutaneous Insulin Infusion Devices for the Management of Pediatric Patients with Type 1 Diabetes: The Supremacy of Hybrid Closed-Loop Systems. [PDF]

Int J Environ Res Public Health, 2022
Bombaci B, Passanisi S, Alibrandi A, D'Arrigo G, Patroniti S, Averna S, Salzano G, Lombardo F.   +7 more
europepmc   +1 more source

Assessment of insulin dose changes in pediatric patients with type 1 diabetes mellitus starting on continuous subcutaneous insulin infusion. [PDF]

J Clin Transl Endocrinol
Gerber S, Kwong GPS, Ho J.
europepmc   +1 more source

Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes. [PDF]

J Diabetes
Gong Y, Wei T, Liu Y, Wang J, Yan J, Yang D, Luo S, Weng J, Zheng X.   +8 more
europepmc   +1 more source

Performance of a Continuous Subcutaneous Insulin Infusion (CSII) Pump With Acoustic Volume and Flow Sensing in Simulated High-Consequence Situations. [PDF]

IEEE Open J Eng Med Biol
Butterfield RD, Sims NM.
europepmc   +1 more source

Continuous Subcutaneous Insulin Infusion and Hypoglycemia

US Endocrinology, 2008
Jerrold Petrofsky, Gurinder Singh Bains, Scott W Lee   +2 more
openaire   +1 more source

Real-time continuous glucose monitoring-guided glucose management in inpatients with diabetes receiving short-term continuous subcutaneous insulin infusion: a randomized clinical trial. [PDF]

Lancet Reg Health West Pac
Wang Y, Lu J, Wang M, Ni J, Yu J, Wang S, Wu L, Lu W, Zhu W, Guo J, Yu X, Bao Y, Zhou J.   +12 more
europepmc   +1 more source

A Three-Arm Randomized Controlled Study Comparing Patient-Reported Outcomes in People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections. [PDF]

J Diabetes Sci Technol
Barnard-Kelly K, Thienel F, Mader JK, Oliver N, Franek E, Vesper I, Dagenbach N, Vogt G, Etter T, Künsting T.   +9 more
europepmc   +1 more source

Efficacy and safety of henagliflozin combined with continuous subcutaneous insulin infusion in the treatment of Chinese inpatients with type 2 diabetes mellitus based on a continuous glucose monitoring system: protocol of a multicentre, open-label, inpatient, randomised, controlled trial. [PDF]

BMJ Open
Wu Y, Huang Z, Qin Y.
europepmc   +1 more source